
Abinza Pharma Private Limited
Manufactures and trades bulk drugs, medicines, APIs, and chemicals.
Manufactures and trades bulk drugs, medicines, APIs, and chemicals.
Abinza Pharma Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 September 2021 (Three years and seven months 19 days old ). Its registered office is in Jammu, Jammu & Kashmir, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company currently has active open charges totaling ₹15.50 Cr.
Sanjeev Goel and Vishav Jindal serve as directors at the Company.
Jammu, Jammu & Kashmir, India
+91-XXXXXXXXXX
U24233JK2021PTC012734
012734
Private Limited Indian Non-Government Company
20 Sep 2021
30 Sep 2024
31 Mar 2024
Unlisted
Roc Jammu
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sanjeev Goel ![]() | Director | 24-Dec-2021 | Current |
Vishav Jindal ![]() | Director | 20-Sep-2021 | Current |
Abinza Pharma Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Abinza Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Sanjeev Goel is a mutual person
Sanjeev Goel is a mutual person
Sanjeev Goel and Vishav Jindal are mutual person
Sanjeev Goel and Vishav Jindal are mutual person
Sanjeev Goel is a mutual person
Sanjeev Goel is a mutual person
₹15.50 Cr
₹0
Date | Lender | Amount | Status |
---|---|---|---|
12 Jul 2023 | Hdfc Bank Limited | ₹15.50 Cr | Open |
Abinza Pharma has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Abinza Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Abinza Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Abinza Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
A charge with Hdfc Bank Limited of Rs. 15.50 Cr registered on 12 Jul 2023 with Charge ID 100745886 was modified on 06 Aug 2024.
Abinza Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Jammu.
A charge with Hdfc Bank Limited amounted to Rs. 15.50 Cr with Charge ID 100745886 was registered on 12 Jul 2023.
Sanjeev Goel was appointed as a Director was appointed as a Director on 24 Dec 2021 & has been associated with this company since 3 years 4 months .
Vishav Nath Jindal was appointed as a Director was appointed as a Director on 20 Sep 2021 & has been associated with this company since 3 years 7 months .
Abinza Pharma Private Limited was incorporated on 20 Sep 2021.
The authorized share capital of Abinza Pharma Private Limited is ₹ 1.00 Cr and paid-up capital is ₹ 1.00 Cr.
Currently 2 directors are associated with Abinza Pharma Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Abinza Pharma Private Limited is C/O Abinza Pharma Pvt. Ltd. Sidco Phase-1 Igc, Samba Kashmir India, Jammu, Jammu & Kashmir, 184121.
The corporate identification number (CIN) of Abinza Pharma Private Limited is U24233JK2021PTC012734 and the company number is 012734 as per Ministry of Corporate Affairs (MCA).
As per the financial statements for fiscal Year 2023, The total open charges for Abinza Pharma Private Limited amount to ₹ 15.50 Cr.
The most recent Balance Sheet for Abinza Pharma Private Limited was filed with the ROC on 31 Mar 2024.
Search company & director profiles for free and gain access to critical business data.
MB
MK